Table 3. Cardiovascular and cerebral responses to leg crossing in standing position.

Values are medians (range). *P<0.05 in comparison to standing before leg cross, †P<0.05 compared with controls.

Measurement	Standing	Leg cross	Standing
MAPheart (mmHg)
Controls	84 (70–95)	90 (74–94)	86 (70–94)
Patients	58 (42–79)†	72 (52–89)*	60 (41–82)†
MAPmca (mmHg)
Controls	62 (56–73)	71 (59–72)	64 (55–72)
Patients	36 (19–58)†	50 (28–73)*	39 (17–62)†
MCA Vmean (cm/s)
Controls	56 (46–77)	64 (46–80)*	57 (47–72)
Patients	55 (38–77)	63 (45–80)*	57 (38–78)
ΔO2Hb (μmol/l)
Controls	0	0.83 (−0.11 to 2.04)	0.69 (−0.11 to 0.93)
Patients	0	1.12 (0.52–3.27)*	0.46 (−0.12 to 0.89)
ΔHHb (μmol/l)
Controls	0	−0.33 (−0.92 to 0.01)	−0.05 (−0.80 to 0.45)
Patients	0	−0.53 (−2.33 to 0.16)	0.07 (−0.23 to 0.66)
PETCO2 (mmHg)
Controls	35 (31–38)	35 (34–42)	35 (33–40)
Patients	36 (28–39)	36 (29–40)	35 (29–39)
HR (beats/min)
Controls	74 (72–86)	71 (58–79)†	73 (65–83)
Patients	75 (64–97)	75 (59–92)	74 (63–95)
SV (%)
Controls	68 (54–85)	84 (73–102)*	69 (61–92)
Patients	54 (45–59)†	62 (56–69)*†	53 (43–61)†
CO (%)
Controls	93 (75–109)	103 (91–119)*	88 (82–114)
Patients	66 (58–79)†	72 (66–95)*†	67 (51–83)†
TPR (%)
Controls	113 (93–126)	105 (82–117)	112 (81–124)
Patients	84 (58–115)†	95 (68–118)*	89 (65–113)
TI (Ohm)
Controls	60 (54–80)	60 (54–78)	61 (54–80)
Patients	60 (55–64)	60 (55–64)	60 (55–64)